NEPHROPLUS NSE filing

Nephroplus Announces 17th AGM on Aug 12, 2026, with Remote E-voting Facility

The RealCase readLow impact Neutral

Nephrocare Health Services Limited will hold its 17th AGM on August 12, 2026, via video conference. Remote e-voting is available from August 8 to August 11, 2026. The Annual Report for FY 2025-26 has been shared with shareholders.

Why it matters

The announcement is a standard procedural update regarding the company's AGM and does not involve any significant financial, operational, or strategic developments.

The market read

The announcement is a routine corporate communication regarding the Annual General Meeting and does not contain information that would significantly impact the company's stock price or financial performance.

Nephrocare Health Services Limited (NEPHROPLUS) has announced its 17th Annual General Meeting (AGM) will be held on Wednesday, August 12, 2026, at 2:30 PM IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM), adhering to the Companies Act, 2013, and SEBI Listing Regulations.

The company has dispatched electronic copies of the AGM Notice and the Annual Report for the financial year 2025-26 to its members. Shareholders who have not registered their email addresses are encouraged to do so to receive these documents. For those whose email addresses are not registered, a letter containing the web-link to the Annual Report was dispatched on July 16, 2026.

NSDL has been appointed as the authorized agency to conduct the AGM via VC/OAVM and to provide remote e-voting and e-voting facilities during the AGM. Remote e-voting will commence on Saturday, August 8, 2026, at 09:00 AM IST and conclude on Tuesday, August 11, 2026, at 05:00 PM IST. Members registered as of the cut-off date, Wednesday, August 5, 2026, are eligible to vote. Facility for e-voting during the AGM will also be available for those attending via VC/OAVM who have not cast their vote remotely.

Filing to action

What to do with a filing like this

Nephrocare Health Services Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Nephrocare Health Services Limited. Read the original for the full detail.

View original filing